Abstract
Hyperresponsiveness is a key abnormality in asthma and deserves recognition both in the clinical presentation of asthma and its pathogenesis. Available evidence strongly suggests that inflammatory processes are important in producing this aspect of disordered airway physiology. Pharmacologic studies have greatly increased our knowledge of mechanisms involved in hyperresponsiveness but fall short of a complete explanation of the phenomenon. It is most likely that hyperresponsiveness, as measured in the laboratory, has many different components and that any single mechanism will be an insufficient explanation.
Similar content being viewed by others
References
Chung KF, Aizawa H, Becker AB, Frick O, Gold WM, Nadel JA (1986) Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs. Am Rev Respir Dis 134:258–261
Chung KF, Aizawa H, Leikauf GD, Ueki IF, Evans TW, Nadel JA (1986) Airway hyperresponsiveness induced by platelet-activating factor: a role of thromboxane generation. J Pharmacol Exp Ther 236:580–584
Chung KF, Becker AB, Lazarus SC, Frick OL, Nadel JA, Gold WM (1985) Antigen-induced airway hyperresponsiveness and pulmonary inflammation in allergic dogs. J Appl Physiol 58:1347–1353
Marsh WR, Irvin CG, Murphy KR, Behrens BL, Larsen GL (1985) Increases in airway reactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in an animal model. Am Rev Respir Dis 131:875–879
Metzger WJ, Sjoerdsma K, Brown L, Coyle T, Page C, Touvay C (1990) The late phase asthmatic response in the allergic rabbit: a role for platelet-activating factor (PAF) and modification by PAF antagonist, ginkgolide BN 52021. Am Rev Respir Dis (in press)
O’Byrne PM, Walters EH, Gold BD, et al. (1984) Indomethacin inhibits the airway hyperresponsiveness but not the neutrophil influx induced by ozone in dogs. Am Rev Respir Dis 130:220–224
Lanes S, Stevenson JS, Codias E, et al. (1986) Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep. J Appl Physiol 61:864–872
Lee HK, Murlas C (1985) Ozone-induced bronchial hyperreactivity in guinea pigs is abolished by BW 755C and FPL 55712 but not indomethacin. Am Rev Respir Dis 132:1005–1009
Murlas C, Roum JH (1985) Sequence of pathologic changes in the airway mucosa of guinea pigs during ozone-induced bronchial hyperreactivity. Am Rev Respir Dis 131:314–320
Murphy KR, Wilson MC, Irvin CG (1986) The requirement for polymorphonuclear leukocytes in the asthmatic response and heightened airway reactivity in an asthmatic model. Am Rev Respir Dis 134:62–68
Abraham WM, Lanes S, Stevenson JS, Yerger LD (1986) Effect of an inhaled glucocorticosteroid (budesonide) on post-antigen induced increases in airway responsiveness. Clin Respir Physiol 22:387–392
Buckner CK, Songsiridej V, Dick EC, Busse WW (1985) In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity. Am Rev Respir Dis 132:305–310
Inoue H, Horio S, Ichinose M, et al. (1986) Changes in bronchial reactivity to acetylcholine with type C influenza virus infection in dogs. Am Rev Respir Dis 133:367–371
Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA (1976) Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 113:131–139
Little JW, Hall WJ, Douglas RG Jr, Muldholkar GS, Speers DM, Patel K (1978) Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Respir Dis 118:295–303
Hirshman CA, Austin DR, Klein W, Hanifin JM, Hulbert W (1986) Increased metachromatic cells and lymphocytes in bronchoalveolar lavage fluid of dogs with airway hyperreactivity. Am Rev Respir Dis 133:482–487
Ahmed T, Krainson JP, Yerger LD (1983) Functional depression of H2 histamine receptors in sheep with experimental allergic asthma. J Allergy Clin Immunol 72:310–320
Nath P, Joshi AP, Agrawal KP (1983) Biochemical correlates of airway hyperreactivity in guinea pigs: role of lysophosphatidyl choline. J Allergy Clin Immunol 72:351–358
Cartier A, Thomson NC, Frith PA, Roberts PA, Hargreave FE (1982) Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway calibre. J Allergy Clin Immunol 70:170–177
Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE (1977) Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 7:503–513
Mattoli S, Foresi A, Corbo GM, Polidori G, Ciappi G (1986) Protective effect of disodium cromoglycate on allergen-induced bronchoconstriction and increased hyperresponsiveness. Ann Allergy 57:295–300
Cockcroft DW, Murdoch KY (1987) Comparative effects of inhaled salbutamol, sodium cromoglycate and beclomethasone diproprionate on allergen-induced early asthmatic responses, late asthmatic responses and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 79:734–740
Rocchichioli K, Pickering CAC, Cole M, Horsfield N (1984) Effect of regular treatment with sodium cromoglycate on non-specific bronchial hyperreactivity. Thorax 33:706
Lowhagen O, Rak S (1985) Modification of bronchial hyperreactivity after treatment with sodium cromoglycate during pollen season. J Allergy Clin Immunol 75:460–467
Israel RH, Poe RH, Wicks CM, Greenblatt DW, Kallay MC (1984) The protective effect of methyl prednisolone on carbachol-induced bronchospasm. Am Rev Respir Dis 130:1019–1022
Bhagat RG, Grunstein MM (1985) Effect of corticosteroids on bronchial responsiveness to methacholine in asthmatic children. Am Rev Respir Dis 131:902–906
Ryan G, Latimer KM, Juniper EF, Roberts RS, Hargreave FE (1985) Effect of beclomethasone diproprionate on bronchial responsiveness to histamine in controlled non-steroid dependent asthma. J Allergy Clin Immunol 75:25–30
Kraan J, Koeter GH, Mark TN, Sluiter HJ, de Vries K (1985) Change in bronchial hyperreactivity induced by four weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budenosine and terbutaline. J Allergy Clin Immunol 76:628–636
Lowhagen O, Rak S (1985) Bronchial hyperreactivity after treatment with sodium cromoglycate in atopic asthmatic patients not exposed to relevant allergens. J Allergy Clin Immunol 75:343–347
Griffin M, Weiss JW, Leitch AG, McFadden ER, Corey EJ, Austen KF, Drazen JM (1983) Effects of leukotriene D on human airways in asthma. N Engl J Med 308:436–439
Adelroth E, Morris MM, Hargreave FE, O’Byrne PM (1986) Airway responsiveness to leukotrienes C4 and D4 and to metacholine in patients with asthma and normal controls. N Engl J Med 315:480–484
Drazen JM, Austen KF (1987) Leukotrienes and airway responses. Am Rev Respir Dis 136:985–998
Barnes NC, Piper PJ, Costello JF (1984) Action of inhaled leukotrienes and their interactions with other allergic mediators. Prostaglandins 28:629–631
Arm JP, Spur BW, Lee TH (1988) The effects of inhaled leukotriene E4 (LTE4) on the airway responsiveness to histamine in subjects with asthma and normal subjects. J Allergy Clin Immunol 82:654–660
Phillips GD, Holgate ST The interactions of inhaled leukotriene C4 with histamine and prostaglandin D2 on airway calibre in asthma. J Appl Physiol (in press)
O’Byrne OM, Leikauf GD, Aizawa H, et al. (1985) Leukotriene B4-induced airway hyperresponsiveness in dogs. J Appl Physiol 59:1941–1946.
Benveniste J, Tence M, Varenne P, Bidault J, Boullet C, Polansky J (1979) Semi-synthèse et structure proposée du facteur activant les plaquettes (PAF): paf-acether, un alkyl ether analogue de la lysophosphatidylcholine. CR Acad Sci Paris 289D:1037–1040
Braquet P, Shen TY, Touqui L, Vargaftig BB (1987) Perspectives in platelet-activating factor research. Pharmacol Rev 39:97–145
Godard P, Chaintreuil J, Damon M, Coupe M, Flandre O, Crastes de Paulet A, Michel FB (1982) Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects. J Allergy Clin Immunol 70:88–93
Lee TC, Lenihan DJ, Malone B, Roddy LL, Wasserman SI (1984) Increased biosynthesis of platelet activating factor in activated human eosinophils. J Biol Chem 259:5526–5530
Barnes PJ, Chung KF (1987) PAF closely mimics pathology of asthma. Trends Pharmacol Sci 8:285–287
Barnes PJ, Chung KF, Page CP (1988) Platelet-activating factor as a mediator of allergic disease. J Allergy Clin Immunol 81:919–934
Schellenberg RR, Walker B, Snyder F (1983) Platelet-dependent contraction of human bronchus by platelet activating factor (Abstract). J Allergy Clin Immunol 71:145.
Holgate ST, Beasley R, Twentyman RO (1987) The pathogenesis and significance of bronchial hyperresponsiveness in airways disease. Clin Sci 73:561–572
Fujimara M, Sasaki F, Nakatsumi Y, Takahashi Y, Hifumi S, Taga K, Mifune JI, Tanaka T, Matsuda T (1986) Effects of thromboxane synthetase (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 41:955–959
Curzen N, Rafferty P, Holgate ST (1987) Cyclooxygenase inhibition and H1-histamine receptor antagonism alone and in combination on allergen-induced bronchoconstriction in man. Thorax 42:946–952
Samter M, Beers RF (1986) Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 68:975–983
Durham SR, Lee TH, Cromwell O, Shaw RJ, Merrett TG, Merrett J, Cooper P, Kay AB (1984) Immunologic studies in allergen-induced late-phase asthmatic reactions. J Allergy Clin Immunol 74:41–60
Naclerio RM, Proud D, Togias AG, Adkinson NF, Meyers DA, Kagey-Sobotka A, Plaut M, Norman PS, Lichtenstein LM (1985) Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 313:65–70
Lichtenstein LM (1988) Histamine releasing factors and IgE-heterogeneity. J Allergy Clin Immunol 81:821–828
Kirby J, Hargreave FE, Gleich GJ, O’Byrne PM (1987) Bronchoalveolar cell profiles of asthmatic and non-asthmatic subjects. Am Rev Respir Dis 136:379–383
Tomioka M, Ida S, Shindoh Y, Ishihara T, Takishima T (1984) Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis 129:1000–1005
Flint KF, Leung KBP, Hudspith BN, Brostoff J, Pearce FL, Johnson NMCI (1985) Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen-specific bronchoconstriction. Br Med J 291:923–926
Lozewics S, Gomez E, Ferguson H, Davies RJ (1988) Mast cells and eosinophils in the bronchial mucous membrane in asthma (Abstract). Thorax 43:238P
Taytard A, Beaumont D, Pajet JC, Sapere M, Lewis PS (1987) Treatment of bronchial asthma with terfenadine in a randomized controlled trial. Br J Clin Pharmacol 24:743–746
Spector SL, Perhach JL, Rorh AS, Rachelefsky GS, Katz RM, Siegel SC (1987) Pharmacodynamic evaluation of azelastine in subjects with asthma. J Allergy Clin Immunol 80:75–80
Storms W, Middleton E, Dvorin D, et al. (1985) Azelastine (azel) in the treatment of asthma (Abstract). J Allergy Clin Immunol 75:167
Fuller RW, Dixon CMS, Dollery CT, Barnes PJ (1986) Prostaglandin D2 potentiates airway responsiveness to histamine and metacholine. Am Rev Respir Dis 133:252–254
Nadel JA, Barnes PJ, Holzman MJ (1986) Autonomic factors in the hyperreactivity of airway smooth muscle. In: Fishman AP, Macklem PT, Mead J, Geiger StR (eds) Handbook of physiology, the respiratory system III. American Physiological Society, pp 693–702
Nadel JA, Barnes PJ (1984) Autonomic regulation of airways. Annu Rev Med 35:451–467
Kaliner MA, Barnes PJ (eds) (1987) The airways: neural control in health and disease. Marcel Dekker, New York
Kaliner M, Shelhamer J, Davis PB, Smith LJ, Venter JC (1982) Autonomic nervous system abnormalities and allergy. Ann Intern Med 96:349–357
Barnes PJ (1986) Airway inflammation and autonomic control. Eur J Respir Dis 1986 69(Suppl 147):80–87
Barnes PJ (1980) Autonomic regulation of airway smooth muscle. In: Nadel JA (ed) Physiology and pharmacology of the airways. Marcel Dekker, New York, pp 217–257
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pauwels, R. The pharmacology of airway hyperresponsiveness and inflammation. Lung 168 (Suppl 1), 221–229 (1990). https://doi.org/10.1007/BF02718136
Issue Date:
DOI: https://doi.org/10.1007/BF02718136